Smiths Group plc (SMIN.L) Bundle
Curious whether Smiths Group plc (SMIN.L) is a buy, hold or sell? Start here: the company delivered 8.9% organic revenue growth in FY2025, beating guidance as reported revenue rose 6.5% to £3.34 billion (with acquisitions contributing 1.4%), while divisional performances ranged from John Crane's 3% organic growth to Smiths Detection's standout 15.2% and Smiths Interconnect's 22.5%-metrics that sit alongside profitability gains including an operating profit margin expansion to 17.4%, organic operating profit up 13.1% to £580m, ROCE improving to 18.1% and EPS climbing 14.8% to 121.2p; liquidity and capital actions are notable too, with operating cash conversion at 99%, free cash flow of £336m, a net debt/EBITDA of 0.6x, £398m of a £500m buyback completed, £121m invested in accretive M&A and the announced £1.3bn sale of Smiths Interconnect to Molex-facts that link directly to valuation signals (a consensus one‑year price target of £27.00 implying ~50% upside) and to clear risks around U.S. construction/semiconductor demand, integration and currency exposure, all of which we unpack in the sections below to give investors the precise data-driven context they need
Smiths Group plc (SMIN.L) Revenue Analysis
Smiths Group delivered robust top-line performance in FY2025, driven by broad-based organic growth across its divisions and selective M&A contribution.- Organic revenue growth: 8.9% (above 6-8% guidance)
- Reported revenue: £3.34 billion, +6.5% year-on-year
- Acquisition contribution to reported growth: 1.4%
Division-level momentum (organic growth shown unless noted):
- John Crane: 3.0% organic revenue growth
- Flex‑Tek: 4.4% organic growth; acquisitions added a further 5.4%
- Smiths Detection: 15.2% organic revenue increase
- Smiths Interconnect: 22.5% organic sales growth
| Metric | FY2025 | YoY Change | Notes |
|---|---|---|---|
| Reported Revenue | £3.34 billion | +6.5% | Includes 1.4% from acquisitions |
| Organic Revenue Growth | 8.9% | + (vs. guidance) | Above 6-8% guidance range |
| John Crane (organic) | - | 3.0% | Aftermarkets and seals demand |
| Flex‑Tek (organic) | - | 4.4% | Acquisitions added 5.4% |
| Smiths Detection (organic) | - | 15.2% | Strong orders and programme wins |
| Smiths Interconnect (organic) | - | 22.5% | High‑performance components demand |
For additional investor context and shareholder activity, see: Exploring Smiths Group plc Investor Profile: Who's Buying and Why?
Smiths Group plc (SMIN.L) - Profitability Metrics
Smiths Group plc delivered a strong performance across core profitability measures in the latest reported period, with notable expansion in margins, cash conversion and returns to shareholders. Key headline metrics illustrate operational leverage and improved capital efficiency, supporting sustainable EPS and cash generation.- Operating profit margin: 17.4% (expanded +60 bps)
- Operating profit (organic): £580 million (+13.1% organic)
- Return on Capital Employed (ROCE): 18.1% (+170 bps)
- Earnings Per Share (EPS): 121.2p (+14.8%)
- Operating cash conversion: 99%
- Free cash flow: £336 million (conversion rate 58%)
| Metric | Value | Change |
|---|---|---|
| Operating profit margin | 17.4% | +60 bps |
| Operating profit (organic) | £580 million | +13.1% |
| Return on Capital Employed (ROCE) | 18.1% | +170 bps |
| Earnings Per Share (EPS) | 121.2p | +14.8% |
| Operating cash conversion | 99% | Improved (to 99%) |
| Free cash flow | £336 million | Conversion rate 58% |
Smiths Group plc (SMIN.L) - Debt vs. Equity Structure
Smiths Group entered FY2025 with a conservative leverage profile and active capital allocation across buybacks, acquisitions and the disposal of Smiths Interconnect. Key headline metrics and transactions shape the balance between debt and equity:- Net debt to EBITDA: 0.6x (reported)
- Share buyback: £398m completed of a £500m program (completed by October 2025)
- Major disposal announced: £1.3bn sale of Smiths Interconnect to Molex (announced October 2025)
- Acquisition activity: £121m invested in accretive acquisitions (aggregate), including a £32m bolt‑on announced March 2025 and £97m invested in accretive acquisitions in H1 FY2025
| Item | Amount | Timing | Balance-sheet/Equity impact |
|---|---|---|---|
| Net debt / EBITDA | 0.6x | FY2025 reported | Low leverage, headroom for M&A or buybacks |
| Share buyback (completed) | £398m of £500m | Completed by Oct 2025 | Reduces shares outstanding; supports EPS and ROE |
| Remaining buyback capacity | £102m | Post-Oct 2025 | Continued equity reduction potential |
| Smiths Interconnect disposal | £1.3bn | Announced Oct 2025 | Large cash inflow / net debt reduction or redeployment capital |
| Total acquisitions (aggregate) | £121m | FY2025 | Adds EBITDA and strategic growth; partially funded from cash/operations |
| Bolt‑on acquisition | £32m | Announced Mar 2025 | Targeted capability expansion |
| Acquisitions H1 FY2025 | £97m | H1 FY2025 | Front‑loaded M&A spend within the year |
- Post-disposal capital options: substantial proceeds from the £1.3bn Interconnect sale materially increase flexibility to extinguish debt, accelerate buybacks (remaining £102m), pursue further accretive M&A, or return capital to shareholders.
- Leverage trajectory: 0.6x net debt/EBITDA pre-disposal indicates low leverage; the disposal is likely to move net debt toward net cash on a pro forma basis unless proceeds are redeployed into further buybacks or M&A.
- EPS and ROE mechanics: the £398m executed buyback reduces share count and supports EPS/ROE; further buyback capacity (£102m) plus proceeds from disposals provide additional leverage to lift shareholder returns.
- M&A trade‑offs: £121m of acquisitions (including £97m in H1 and a £32m bolt‑on) show continued reinvestment into the portfolio - accretive deals can raise operating profit and offset the dilutive effects of higher cash balances.
Smiths Group plc (SMIN.L) - Liquidity and Solvency
Smiths Group demonstrates strong cash generation and active capital deployment, underpinned by near-complete operating cash conversion and sizeable strategic transactions in 2024-2025.- Operating cash conversion rate: 99% - indicates almost full conversion of operating profit into cash.
- Free cash flow: £336 million with a conversion rate of 58% - solid FCF enabling returns and M&A.
- Share buyback: £398 million of a £500 million programme completed by October 2025 (remaining £102 million).
- M&A: £121 million invested in accretive acquisitions plus a £32 million bolt-on announced March 2025.
- Portfolio disposal: £1.3 billion sale of Smiths Interconnect to Molex announced October 2025 - significant liquidity event.
| Metric | Value | Notes |
|---|---|---|
| Operating cash conversion | 99% | Near-total conversion of operating profit to cash |
| Free cash flow | £336m | FCF conversion rate 58% |
| Share buyback completed | £398m of £500m | Completed by Oct 2025; £102m remaining |
| Accretive acquisitions | £121m | Targeted strategic bolt-ons |
| Bolt-on acquisition (Mar 2025) | £32m | Small-scale complement to existing businesses |
| Disposal proceeds (Smiths Interconnect) | £1.3bn | Announced Oct 2025 to Molex - major liquidity boost |
| Net immediate liquidity impact (simple sum) | £749m | £1.3bn sale - £398m buyback - £121m acquisitions - £32m bolt-on |
- Balance sheet flexibility: the £1.3bn disposal plus ongoing strong cash conversion materially strengthens liquidity and offers capacity to reduce leverage, complete remaining buybacks, or fund further M&A.
- Solvency considerations: high operating cash conversion and positive free cash flow reduce refinancing risk; proceeds from the Interconnect sale provide a buffer for longer-term capital structure optimisation.
Smiths Group plc (SMIN.L) - Valuation Analysis
Smiths Group plc is being valued against a mix of near-term operational metrics, capital allocation actions and one-off portfolio transactions that materially affect investor returns and earnings per share dynamics. Key headline figures driving the current valuation narrative include an average one-year price target of £27.00 (implying ~50% upside), projected FY revenue and EPS, an active share buyback program, acquisitions, and the large divestment announced in October 2025.- Analyst consensus one-year price target: £27.00 - implies ~50% upside from recent levels.
- Projected annual revenue: £2,883 million (down 1.10% year-over-year).
- Projected annual non-GAAP EPS: £0.94.
- Share buyback progress: £398 million of a £500 million program completed by October 2025.
- Acquisitions: £121 million invested in accretive acquisitions.
- Major divestment: £1.3 billion sale of Smiths Interconnect to Molex announced October 2025.
| Metric | Value | Notes |
|---|---|---|
| Avg. 1-yr Price Target | £27.00 | ~50% implied upside vs. market price |
| Projected Revenue (FY) | £2,883m | -1.10% YoY |
| Projected non-GAAP EPS | £0.94 | Post-divestment/acquisitions basis |
| Share Buyback | £398m of £500m | Completed by Oct 2025; remaining £102m |
| Acquisitions (capex/ M&A) | £121m | Targeted accretive deals |
| Divestment | £1.3bn | Sale of Smiths Interconnect to Molex (Oct 2025) |
- EPS outlook: Projected non-GAAP EPS of £0.94 should be evaluated against legacy EPS trends and the pro-forma impact of the Interconnect sale (cash inflow vs. lost operating earnings).
- Share buybacks: £398m executed (~79.6% of the £500m target) supports EPS accretion and shareholder return; remaining £102m could further reduce share count and amplify EPS if deployed.
- Balance sheet impact: The £1.3bn proceeds from the Interconnect divestment materially improve liquidity and deleverage capacity, enabling buybacks, M&A, or special distributions.
- M&A deployment: £121m of accretive acquisitions demonstrates management's intent to redeploy capital into higher-return businesses; assess revenue and margin contribution timelines.
- Revenue trajectory: A slight decline (-1.10%) to £2,883m signals cyclicality or portfolio reshaping; investors should monitor organic growth vs. inorganic shifts.
- Valuation multiple sensitivity: With a consensus price target of £27.00, implied multiples depend on forward EPS and net cash post-sale/buyback - run scenario analyses on EPS uplift from buybacks and use of sale proceeds.
Smiths Group plc (SMIN.L) - Risk Factors
- Weak demand in U.S. construction and semiconductor markets affecting Flex-Tek and Smiths Interconnect divisions
- Revenue sensitivity: combined contribution from these businesses historically ranges from ~15%-25% of group revenue, meaning a 10% drop in those end markets can translate to a 1.5%-2.5% hit to total group top line.
- Order book and lead indicators: order intake in semiconductor‑related products tends to be lumpy; a slowdown in chip capital spending can depress order intake for several quarters.
| Metric | Approx. Recent Value | Relevance to Risk |
|---|---|---|
| Group revenue (FY) | ~£2.3-2.5bn | Size of demand shock impact |
| Flex‑Tek / Interconnect revenue share | ~15%-25% | Concentration of exposure |
| Quarterly order volatility | ±10% typical swings in cyclical quarters | Cash flow and backlog uncertainty |
- Investment implications: monitor monthly/quarterly order trends, U.S. housing starts, and semiconductor capital expenditure guidance to gauge near‑term earnings risk.
- Potential impact of Smiths Interconnect sale on future revenue streams
- Immediate P&L: sale proceeds boost cash and can improve leverage metrics (net debt / EBITDA) but reduce recurring revenue base by the sold division's share (~several hundred million GBP in revenue if typical scale).
- Profitability mix: divestment may improve group margins if the remaining portfolio is higher‑margin, or worsen margins if the disposed business was accretive.
- Investor perception: proceeds may be redeployed for buybacks, debt reduction, or M&A; track stated capital allocation priorities.
| Scenario | Short‑term effect | Medium‑term effect |
|---|---|---|
| Sale proceeds redeployed to buybacks | EPS accretion, higher share price support | Lower cash cushion, dependent on cycle |
| Proceeds used to pay down debt | Improved leverage (net debt/EBITDA) | Lower interest cost, but smaller scale for growth investments |
| Sale not completed / delayed | Ongoing revenue volatility | Strategic uncertainty; potential distraction |
- Integration risks associated with recent acquisitions
- Execution: cost synergies may take longer than modeled; dilution of margin if acquired businesses underperform.
- Cultural and systems: integration of IT, ERP and local teams can incur one‑off costs and distract management.
- Financial: purchase price allocations, goodwill and potential impairment risk if forecasts aren't met.
- Exposure to currency fluctuations affecting international operations
- Translation exposure: a stronger pound reduces sterling‑reported revenue and operating profit from overseas operations; recent FX moves have caused quarter‑on‑quarter translation effects in the low single digits of revenue.
- Transactional exposure: raw material and component costs invoiced in USD/EUR can compress gross margins if not hedged.
- Hedging: the company typically uses hedging instruments-assess level of hedged sales/expenses in financial notes.
| FX Element | Typical Impact | Investor Watch |
|---|---|---|
| Translation | ±1%-3% revenue swing per 5-10% GBP move | Hedging policy disclosure in annual report |
| Transactional | Margin compression if unhedged | Gross margin trends and FX sensitivity tables |
- Regulatory changes impacting product lines and operations
- Compliance costs: new safety or environmental rules can increase capex and operating costs for manufacturing sites.
- Export controls: restrictions on dual‑use or defense‑related components can limit addressable markets for Interconnect products.
- Certification timelines: delays in regulatory approvals (medical, aerospace, energy) can push out revenue recognition.
- Competitive pressures in core industrial technology markets
- Pricing pressure: commoditisation in certain product families can erode margins unless offset by higher value aftermarket or service revenues.
- Innovation race: maintaining R&D intensity and product differentiation is necessary to defend share in sensors, connectors and engineered products.
- M&A by peers: consolidation among competitors can create larger rivals with scale advantages.
Smiths Group plc (SMIN.L) - Growth Opportunities
Smiths Group plc (SMIN.L) is sharpening its portfolio toward higher-margin, industrial technology businesses-primarily John Crane and Flex-Tek-while monetising non-core assets and returning capital to shareholders. Recent and ongoing actions create multiple potential value levers for investors, combining organic growth, targeted M&A, balance sheet optimisation and structural separation to crystallise value.- Core focus: high-performance industrial technology-John Crane (rotating equipment seals, reliability services) and Flex-Tek (engineered thermal and fluid management solutions).
- Portfolio simplification: sale of Smiths Interconnect for £1.3 billion to Molex-provides capital for reinvestment and shareholder returns.
- Bolt-on M&A: £32 million acquisition announced March 2025 to strengthen technology and route-to-market in key end-markets.
- Acquisition cadence: £121 million invested in accretive acquisitions in H1 FY2025 to accelerate capability and revenue mix shift.
- Structural unlock: progressing separation of Smiths Detection to create two pure-play businesses and potentially close valuation discount.
- Shareholder returns: £398 million of the £500 million buyback completed by October 2025-~79.6% executed, supporting EPS and ROE.
| Item | Value / Date | Commentary |
|---|---|---|
| Sale of Smiths Interconnect | £1.3 billion (to Molex) | Major non-core disposal freeing capital for core investments and buybacks |
| Bolt-on acquisition | £32 million (announced Mar 2025) | Targeted add-on to boost John Crane/Flex-Tek capabilities |
| Acquisitions (H1 FY2025) | £121 million | Accretive deals to accelerate growth and margin expansion |
| Share buyback program | £500 million target; £398 million completed (Oct 2025) | ~79.6% completed; reduces shares outstanding and supports EPS |
| Separation program | Smiths Detection separation (in progress) | Strategic refocus to pure-play industrial technologies |
- Balance-sheet flexibility: £1.3bn disposal plus ongoing cash generation funds acquisitions (£121m H1 FY2025) and buybacks (£398m executed), limiting leverage pressure while enabling growth.
- EPS and return enhancement: substantial buyback (~79.6% of £500m) supports EPS accretion; accretive acquisitions should further lift margins over time.
- Portfolio quality uplift: concentration on John Crane and Flex-Tek targets markets with structural demand (energy transition, industrial reliability, HVAC, thermal management), improving organic growth prospects and margin profiles.
- Potential re-rating: progressing separation of Smiths Detection aims to unlock valuation by creating two clearer investment propositions-pure-play industrial technology and a standalone detection business.
| Period | Activity | Cash / Value |
|---|---|---|
| 2024-2025 | Sale of Smiths Interconnect | £1.3 billion |
| H1 FY2025 | Accretive acquisitions | £121 million |
| Mar 2025 | Bolt-on acquisition | £32 million |
| By Oct 2025 | Share buyback executed | £398 million of £500 million |

Smiths Group plc (SMIN.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.